Selected research
Industry Research
Freund Adjuvant Industry Research Report 2026
Market perspective
The global Freund Adjuvant market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Freund Adjuvant is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Freund Adjuvant is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Freund Adjuvant is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Freund Adjuvant include Shanghai Maokang Biotechnology, DIYIBio, Beyotime, Wako Pure Chemical Industries, Thermo Scientific, Sigma Aldrich, Rockland Immunochemicals, MP Biomedicals and InvivoGen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Freund Adjuvant market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Freund Adjuvant Market by Company
Shanghai Maokang Biotechnology
DIYIBio
Beyotime
Wako Pure Chemical Industries
Thermo Scientific
Sigma Aldrich
Rockland Immunochemicals
MP Biomedicals
InvivoGen
Creative Diagnostics
Advanced Biomart
Freund Adjuvant Segment by Type
Freunds Complete Adjuvant (FCA)
Freunds Incomplete Adjuvant (FICA)
Freund Adjuvant Segment by Application
Medicine
Scientific Research
Freund Adjuvant Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Freund Adjuvant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Freund Adjuvant and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Freund Adjuvant.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Freund Adjuvant manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Freund Adjuvant by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Freund Adjuvant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Freunds Complete Adjuvant (FCA)
- Freunds Incomplete Adjuvant (FICA)
Applications
- Medicine
- Scientific Research
Companies covered
- Shanghai Maokang Biotechnology
- DIYIBio
- Beyotime
- Wako Pure Chemical Industries
- Thermo Scientific
- Sigma Aldrich
- Rockland Immunochemicals
- MP Biomedicals
- InvivoGen
- Creative Diagnostics
- Advanced Biomart
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Freund Adjuvant Market Size (2021-2032)
- 2.2.2 Global Freund Adjuvant Sales (2021-2032)
- 2.2.3 Global Freund Adjuvant Market Average Price (2021-2032)
- 2.3 Freund Adjuvant by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Freunds Complete Adjuvant (FCA)
- 2.3.3 Freunds Incomplete Adjuvant (FICA)
- 2.4 Freund Adjuvant by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Medicine
- 2.4.3 Scientific Research
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Freund Adjuvant Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Freund Adjuvant Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Freund Adjuvant Revenue of Manufacturers (2021-2026)
- 3.4 Global Freund Adjuvant Average Price by Manufacturers (2021-2026)
- 3.5 Global Freund Adjuvant Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Freund Adjuvant, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Freund Adjuvant, Product Type & Application
- 3.8 Global Manufacturers of Freund Adjuvant, Established Date
- 3.9 Global Freund Adjuvant Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Shanghai Maokang Biotechnology
- 4.1.1 Shanghai Maokang Biotechnology Company Information
- 4.1.2 Shanghai Maokang Biotechnology Business Overview
- 4.1.3 Shanghai Maokang Biotechnology Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Shanghai Maokang Biotechnology Freund Adjuvant Product Portfolio
- 4.1.5 Shanghai Maokang Biotechnology Recent Developments
- 4.2 DIYIBio
- 4.2.1 DIYIBio Company Information
- 4.2.2 DIYIBio Business Overview
- 4.2.3 DIYIBio Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 DIYIBio Freund Adjuvant Product Portfolio
- 4.2.5 DIYIBio Recent Developments
- 4.3 Beyotime
- 4.3.1 Beyotime Company Information
- 4.3.2 Beyotime Business Overview
- 4.3.3 Beyotime Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Beyotime Freund Adjuvant Product Portfolio
- 4.3.5 Beyotime Recent Developments
- 4.4 Wako Pure Chemical Industries
- 4.4.1 Wako Pure Chemical Industries Company Information
- 4.4.2 Wako Pure Chemical Industries Business Overview
- 4.4.3 Wako Pure Chemical Industries Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Wako Pure Chemical Industries Freund Adjuvant Product Portfolio
- 4.4.5 Wako Pure Chemical Industries Recent Developments
- 4.5 Thermo Scientific
- 4.5.1 Thermo Scientific Company Information
- 4.5.2 Thermo Scientific Business Overview
- 4.5.3 Thermo Scientific Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Thermo Scientific Freund Adjuvant Product Portfolio
- 4.5.5 Thermo Scientific Recent Developments
- 4.6 Sigma Aldrich
- 4.6.1 Sigma Aldrich Company Information
- 4.6.2 Sigma Aldrich Business Overview
- 4.6.3 Sigma Aldrich Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sigma Aldrich Freund Adjuvant Product Portfolio
- 4.6.5 Sigma Aldrich Recent Developments
- 4.7 Rockland Immunochemicals
- 4.7.1 Rockland Immunochemicals Company Information
- 4.7.2 Rockland Immunochemicals Business Overview
- 4.7.3 Rockland Immunochemicals Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Rockland Immunochemicals Freund Adjuvant Product Portfolio
- 4.7.5 Rockland Immunochemicals Recent Developments
- 4.8 MP Biomedicals
- 4.8.1 MP Biomedicals Company Information
- 4.8.2 MP Biomedicals Business Overview
- 4.8.3 MP Biomedicals Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 MP Biomedicals Freund Adjuvant Product Portfolio
- 4.8.5 MP Biomedicals Recent Developments
- 4.9 InvivoGen
- 4.9.1 InvivoGen Company Information
- 4.9.2 InvivoGen Business Overview
- 4.9.3 InvivoGen Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 InvivoGen Freund Adjuvant Product Portfolio
- 4.9.5 InvivoGen Recent Developments
- 4.10 Creative Diagnostics
- 4.10.1 Creative Diagnostics Company Information
- 4.10.2 Creative Diagnostics Business Overview
- 4.10.3 Creative Diagnostics Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Creative Diagnostics Freund Adjuvant Product Portfolio
- 4.10.5 Creative Diagnostics Recent Developments
- 4.11 Advanced Biomart
- 4.11.1 Advanced Biomart Company Information
- 4.11.2 Advanced Biomart Business Overview
- 4.11.3 Advanced Biomart Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Advanced Biomart Freund Adjuvant Product Portfolio
- 4.11.5 Advanced Biomart Recent Developments
5 Global Freund Adjuvant Market Scenario by Region
- 5.1 Global Freund Adjuvant Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Freund Adjuvant Sales by Region: 2021-2032
- 5.2.1 Global Freund Adjuvant Sales by Region: 2021-2026
- 5.2.2 Global Freund Adjuvant Sales by Region: 2027-2032
- 5.3 Global Freund Adjuvant Revenue by Region: 2021-2032
- 5.3.1 Global Freund Adjuvant Revenue by Region: 2021-2026
- 5.3.2 Global Freund Adjuvant Revenue by Region: 2027-2032
- 5.4 North America Freund Adjuvant Market Facts & Figures by Country
- 5.4.1 North America Freund Adjuvant Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Freund Adjuvant Sales by Country (2021-2032)
- 5.4.3 North America Freund Adjuvant Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Freund Adjuvant Market Facts & Figures by Country
- 5.5.1 Europe Freund Adjuvant Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Freund Adjuvant Sales by Country (2021-2032)
- 5.5.3 Europe Freund Adjuvant Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Freund Adjuvant Market Facts & Figures by Country
- 5.6.1 Asia Pacific Freund Adjuvant Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Freund Adjuvant Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Freund Adjuvant Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Freund Adjuvant Market Facts & Figures by Country
- 5.7.1 South America Freund Adjuvant Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Freund Adjuvant Sales by Country (2021-2032)
- 5.7.3 South America Freund Adjuvant Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Freund Adjuvant Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Freund Adjuvant Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Freund Adjuvant Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Freund Adjuvant Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Freund Adjuvant Sales by Type (2021-2032)
- 6.1.1 Global Freund Adjuvant Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Freund Adjuvant Sales Market Share by Type (2021-2032)
- 6.2 Global Freund Adjuvant Revenue by Type (2021-2032)
- 6.2.1 Global Freund Adjuvant Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Freund Adjuvant Revenue Market Share by Type (2021-2032)
- 6.3 Global Freund Adjuvant Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Freund Adjuvant Sales by Application (2021-2032)
- 7.1.1 Global Freund Adjuvant Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Freund Adjuvant Sales Market Share by Application (2021-2032)
- 7.2 Global Freund Adjuvant Revenue by Application (2021-2032)
- 7.2.1 Global Freund Adjuvant Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Freund Adjuvant Revenue Market Share by Application (2021-2032)
- 7.3 Global Freund Adjuvant Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Freund Adjuvant Value Chain Analysis
- 8.1.1 Freund Adjuvant Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Freund Adjuvant Production Mode & Process
- 8.2 Freund Adjuvant Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Freund Adjuvant Distributors
- 8.2.3 Freund Adjuvant Customers
9 Global Freund Adjuvant Analyzing Market Dynamics
- 9.1 Freund Adjuvant Industry Trends
- 9.2 Freund Adjuvant Industry Drivers
- 9.3 Freund Adjuvant Industry Opportunities and Challenges
- 9.4 Freund Adjuvant Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst